ZA757865B - Improvements relating to xanthine derivatives - Google Patents

Improvements relating to xanthine derivatives

Info

Publication number
ZA757865B
ZA757865B ZA757865A ZA757865A ZA757865B ZA 757865 B ZA757865 B ZA 757865B ZA 757865 A ZA757865 A ZA 757865A ZA 757865 A ZA757865 A ZA 757865A ZA 757865 B ZA757865 B ZA 757865B
Authority
ZA
South Africa
Prior art keywords
improvements relating
xanthine derivatives
xanthine
derivatives
relating
Prior art date
Application number
ZA757865A
Other languages
English (en)
Inventor
R Reichl
W Konz
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of ZA757865B publication Critical patent/ZA757865B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA757865A 1974-12-21 1975-12-19 Improvements relating to xanthine derivatives ZA757865B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742460929 DE2460929A1 (de) 1974-12-21 1974-12-21 Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung

Publications (1)

Publication Number Publication Date
ZA757865B true ZA757865B (en) 1977-08-31

Family

ID=5934312

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA757865A ZA757865B (en) 1974-12-21 1975-12-19 Improvements relating to xanthine derivatives

Country Status (31)

Country Link
US (1) US3998953A (fr)
JP (1) JPS5188995A (fr)
AT (1) AT341540B (fr)
AU (1) AU501889B2 (fr)
BE (1) BE836898A (fr)
BG (1) BG25518A3 (fr)
CA (1) CA1036159A (fr)
CH (1) CH628346A5 (fr)
CS (1) CS191289B2 (fr)
DD (1) DD124984A5 (fr)
DE (1) DE2460929A1 (fr)
DK (1) DK137677C (fr)
ES (2) ES443738A1 (fr)
FI (1) FI62089C (fr)
FR (1) FR2294706A1 (fr)
GB (1) GB1517710A (fr)
GR (1) GR59204B (fr)
HU (1) HU174673B (fr)
IE (1) IE43208B1 (fr)
IL (1) IL48697A (fr)
LU (1) LU73972A1 (fr)
NL (1) NL7514837A (fr)
NO (1) NO144928C (fr)
NZ (1) NZ179599A (fr)
PH (1) PH11810A (fr)
PL (1) PL99165B1 (fr)
RO (1) RO68381A (fr)
SE (1) SE420493B (fr)
SU (1) SU603340A3 (fr)
YU (1) YU39004B (fr)
ZA (1) ZA757865B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337254A (en) * 1977-08-23 1982-06-29 Burroughs Wellcome Co. Pharmaceutical compositions
DE3113880A1 (de) * 1981-04-07 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von coffein
IT1174773B (it) * 1983-07-29 1987-07-01 Medosan Ind Biochimi Attivita' antiaggregante piastrinica e broncolitica della 7-(1-metil-5-p-metilbenzoilpirrol-2-acetamidoetil)teofillina
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5620676A (en) * 1994-03-08 1997-04-15 The United States Of America As Represented By The Department Of Health And Human Services Biologically active ATP analogs
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
WO1999031101A1 (fr) * 1997-12-17 1999-06-24 University Of South Florida Antagonistes du recepteur de l'adenosine presentant une bioactivite amelioree
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1230663A (fr) * 1968-12-10 1971-05-05
US3728346A (en) * 1971-07-16 1973-04-17 Degussa Hydroxyphenylhydroxyalkylaminoalkyltheophyllines
JPS5132638B2 (fr) * 1972-07-13 1976-09-14

Also Published As

Publication number Publication date
FR2294706A1 (fr) 1976-07-16
LU73972A1 (fr) 1977-02-15
NO754317L (fr) 1976-06-22
NO144928C (no) 1981-12-09
SE420493B (sv) 1981-10-12
NL7514837A (nl) 1976-06-23
IE43208B1 (en) 1981-01-14
DK137677C (da) 1978-09-25
DE2460929C2 (fr) 1987-12-17
NZ179599A (en) 1978-03-06
DK571875A (da) 1976-06-22
IL48697A (en) 1979-07-25
YU323475A (en) 1982-08-31
ATA904575A (de) 1977-06-15
NO144928B (no) 1981-08-31
SE7514477L (sv) 1976-06-22
FI62089B (fi) 1982-07-30
PH11810A (en) 1978-07-10
HU174673B (hu) 1980-03-28
GB1517710A (en) 1978-07-12
BG25518A3 (en) 1978-10-10
JPS5188995A (fr) 1976-08-04
FR2294706B1 (fr) 1978-12-01
BE836898A (fr) 1976-06-21
SU603340A3 (ru) 1978-04-15
YU39004B (en) 1983-12-31
CS191289B2 (en) 1979-06-29
AU501889B2 (en) 1979-07-05
GR59204B (en) 1977-11-26
ES443738A1 (es) 1977-04-16
DK137677B (da) 1978-04-17
PL99165B1 (pl) 1978-06-30
US3998953A (en) 1976-12-21
RO68381A (fr) 1982-02-26
FI62089C (fi) 1982-11-10
FI753543A (fr) 1976-06-22
DE2460929A1 (de) 1976-06-24
IL48697A0 (en) 1976-02-29
DD124984A5 (fr) 1977-03-23
IE43208L (en) 1976-06-21
CH628346A5 (de) 1982-02-26
CA1036159A (fr) 1978-08-08
AT341540B (de) 1978-02-10
AU8754775A (en) 1977-06-23
ES451457A1 (es) 1977-10-01

Similar Documents

Publication Publication Date Title
PH11652A (en) Arloxphenylpropylamines derivatives
IL48592A0 (en) Novel 1-substituted-4-benzylpiperidine derivatives
IL48593A0 (en) Novel 1-substituted-4-benzylidenepiperidine derivatives
ZA753968B (en) Novel benzimidazolinone derivatives
IL46341A0 (en) Alpha-aryl-4-substituted piperidinoalkanol derivatives
AU8330675A (en) Pyrimidine derivatives
GB1519811A (en) Thienothaiazine derivatives
PH12312A (en) Thienothiazine derivatives
ZA757828B (en) 2-methoxy-benzamide derivatives
AU1038176A (en) 4-arylpiperidine derivatives
AU7921975A (en) Hexahydro-alpha-carboline derivatives
GB1484049A (en) 3-alkoxy-pyrazine-2-carboxamide derivatives
ZA753272B (en) Improvements relating to pyridobenzodiazepinones
GB1521320A (en) Quinolisidine derivatives
ZA757865B (en) Improvements relating to xanthine derivatives
ZA753315B (en) Oxacyclohexane derivatives
PH12265A (en) Benzo-bicyclononene derivatives
ZA755543B (en) Thiomethylcephem derivatives
IL48409A0 (en) Phenyl-pyridylamine derivatives
ZA753299B (en) Amidino-hydrazone derivatives
JPS5126235A (en) Budooto to katooganjusuru ekiseigongobutsu no shorihoho
ZA757303B (en) Xanthine derivatives
JPS51115457A (en) 166methyll9 alphaa halosteroid derivatives
GB1486646A (en) Thieno-pyridine derivatives
ZA752989B (en) Improvements in or relating to penicillins